These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6942296)

  • 21. The effect of a lipid extract of the New Zealand green-lipped mussel in three cases of arthritis.
    Gibson SL
    J Altern Complement Med; 2000 Aug; 6(4):351-4. PubMed ID: 10976982
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatty acid and sterol composition of frozen and freeze-dried New Zealand Green Lipped Mussel (Perna canaliculus) from three sites in New Zealand.
    Murphy KJ; Mann NJ; Sinclair AJ
    Asia Pac J Clin Nutr; 2003; 12(1):50-60. PubMed ID: 12737011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus.
    McPhee S; Hodges LD; Wright PF; Wynne PM; Kalafatis N; Harney DW; Macrides TA
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Mar; 146(3):346-56. PubMed ID: 17197217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CO2-SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant-induced arthritis in rats.
    Singh M; Hodges LD; Wright PF; Cheah DM; Wynne PM; Kalafatis N; Macrides TA
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Feb; 149(2):251-8. PubMed ID: 17931921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial.
    Cho SH; Jung YB; Seong SC; Park HB; Byun KY; Lee DC; Song EK; Son JH
    Eur Ann Allergy Clin Immunol; 2003 Jun; 35(6):212-6. PubMed ID: 12872680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effects of mussel extracts.
    Miller TE
    N Z Med J; 1981 Jan; 93(675):23-4. PubMed ID: 6937800
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of the progression of adjuvant induced arthritis by oral supplementation of Indian fresh water mussel (Lamellidens marginalis) aqueous extract in experimental rats.
    Chakraborty M; Bhattacharya S; Bhattacharjee P; Das R; Mishra R
    J Ethnopharmacol; 2010 Oct; 132(1):316-20. PubMed ID: 20728518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus.
    Treschow AP; Hodges LD; Wright PF; Wynne PM; Kalafatis N; Macrides TA
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):645-56. PubMed ID: 17543561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls and dilemmas in the management of rheumatoid arthritis.
    Christophidis N
    Aust Fam Physician; 1985 Dec; 14(12):1324, 1327, 1329. PubMed ID: 3833177
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment with pituitary stimulation in rheumatoid arthritis. Physiopathological and clinical data on posterior-pituitary opotherapy].
    Giacovazzo M; Ippolito A; Giovannini C; Spagna G; Maglione P
    Minerva Med; 1968 Oct; 59(81):4308-15. PubMed ID: 4301057
    [No Abstract]   [Full Text] [Related]  

  • 31. A method of preparation of a tissue vaccine for patients with rheumatoid arthritis.
    Cobey MC; Blundell GP
    Clin Orthop Relat Res; 1968; 61():277-8. PubMed ID: 5704413
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-inflammatory and chondroprotective effects of nutraceuticals from Sasha's Blend in a cartilage explant model of inflammation.
    Pearson W; Orth MW; Karrow NA; Maclusky NJ; Lindinger MI
    Mol Nutr Food Res; 2007 Aug; 51(8):1020-30. PubMed ID: 17639996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The comparative characteristics of the anti-inflammatory action of chorionic and placental extracts].
    Klymenko MO; Subota NP; Pit'ko VA; Tatarko SV
    Fiziol Zh (1994); 2000; 46(1):32-6. PubMed ID: 10758828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of rheumatoid arthritis: current and future].
    Bentin J
    Rev Med Brux; 1993 Jun; 14(6):175-81. PubMed ID: 8367633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rheumatoid arthritis. Medical and surgical treatment].
    Karneff A
    Soins; 1996 Jun; (607):14-9. PubMed ID: 8718289
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of rheumatoid arthritis in the year 2000].
    Leirisalo-Repo M
    Duodecim; 1993; 109(7):626-31. PubMed ID: 8062734
    [No Abstract]   [Full Text] [Related]  

  • 38. The medical management of rheumatoid arthritis.
    Silver RM
    J S C Med Assoc; 1982 Nov; 78(11):593-8. PubMed ID: 6960213
    [No Abstract]   [Full Text] [Related]  

  • 39. Connective tissue activation in vitro: suppression by antirheumatic drugs.
    Castor CW
    J Lab Clin Med; 1971 Nov; 78(5):851. PubMed ID: 5128906
    [No Abstract]   [Full Text] [Related]  

  • 40. Orgotein in the treatment of rheumatoid arthritis.
    Menander-Huber KB
    Eur J Rheumatol Inflamm; 1981; 4(2):201-11. PubMed ID: 7044787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.